Placebo-controlled clinical trial with soy isoflavones for depressive symptoms in climacteric women;Ensaio clínico placebo-controlado com isoflavonas da soja para sintomas depressivos em mulheres no climatério

Revista Brasileira de Ginecologia e Obstetricia

Volumn 28, Issue 2, 2006, Pages 91-100

  De Sousa, Rilva Lopes ^a,b   Filizola, Rosália Gouveia ^a   Diniz, Margareth De Fátima Formiga Melo ^a   Sousa, Eduardo Sérgio Soares ^a   De Moraes, João Leonardo Ribeiro ^a  

^a FEDERAL UNIVERSITY OF PARAÍBA   (Brazil)

^b NONE   (Brazil)

Author keywords

Climacteric; Depression; Estrogens, non steroidal; Isoflavones; Women's health

Indexed keywords

EID: 33747817683     PISSN: 01007203     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0100-72032006000200004     Document Type: Article

References (40)

1. Koike K, Ohno S, Takahashi N, Suzuki N, Nozaki N, Murakami K, et al. Efficacy of the herbal medicine Unkeito as an adjunctive treatment to hormone replacement therapy for postmenopausal women with depressive symptoms. Clin Neuropharmacol. 2004;27(4):157-62.
2. Schechter D. Estrogen, progesterone, and mood. J Gend Specific Med. 1999;2(1):29-36.
3. Schiff R, Bulpitt CJ, Wesnes KA, Rajkumar C. Short-term transdermal estradiol therapy, cognition and depressive symptoms in healthy older women: A randomized placebo controlled pilot cross-over study. Psychoneuroendocrinology. 2005;30(4):309-15.
4. Haines CJ, Yim SF, Chung TK, Lam CW, Lau EW, Ng MH, et al. A prospective, randomized, placebo-controlled study of the dose effect of oral oestradiol on menopausal symptoms, psychological well being, and quality of life in postmenopausal Chinese women. Maturitas. 2003;44(3):207-14.
5. Rudolph I, Zimmerman T, Zaminski K, Jandova K, Borovsky B, Ahrendt HJ, et al. Changes in psychic and somatic well-being and cognitive capabilities of peri- and postmenopausal women after use of a hormone replacement therapy containing estradiol valerate and levonorgestrel. Methods Find Exp Clin Pharmacol. 2000;22(1):51-6.
6. Souza RL, Filizola RG, Souza ESS, Moraes JLR. Efeito de hormônios sexuais femininos sobre sintomatologia depressiva no climatério. Reprod Clim. 2001;16(2):118-22.
7. Kaari C, Haidar MA, Soares Júnior JM, Nunes MG, Quadros LG, Kemp C, et al. Randomized clinical trial comparing conjugated equine estrogens and isoflavones in postmenopausal women: a pilot study. Maturitas. 2006;53(1):49-58.
8. Crisafulli A, Marini H, Bitto A, Altavilla D, Squadrito D, Romeo A, et al. Effects of genistein on hot flushes in early postmenopausal women: a randomized, double-blind EPT- and placebo-controlled study. Menopause. 2004;11(4):400-4.
9. Faure ED, Chantre P, Mares P. Effects of a standardized soy extract on hot flushes: a multicenter, double-blind, randomized, placebo-controlled study. Menopause. 2002;9(5):329-34.
10. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56-62.
11. Organização Mundial da Saúde. Classificaç ão de transtornos mentais e de comportamento da CID-10: descrições clínicas e diretrizes diagnósticas. Porto Alegre: Artes Médicas; 1993.
12. A decision tree for the use of estrogen replacement therapy on hormone replacement therapy in postmenopausal women: consensus opinion of The North American Menopause Society. Menopause. 2000;7(2):76-86.
13. Moraes JLR. Depressão no Hospital Geral: freqüência de pacientes deprimidos na clientela de internos do Hospital Universitário Lauro Wanderley [dissertação]. Recife: Universidade Federal de Pernambuco; 1996.
14. Associação Brasileira de Empresas de Pesquisa [homepage da Internet]. Critério de classificação econômica Brasil. 2003 [acesso 22 mar 2003]. Disponível em: http://www.anep.org.br/ codigosguias/ABEP_CCEB.pdf.
15. Liu P, He FF, Bai WP, Yu Q, Shi W, Wu YY, et al. Menopausal depression: comparison of hormone replacement therapy and hormone replacement therapy plus fluoxetine. Chin Med J (Engl). 2004;117(2):189-94.
16. Cohen J. Statistical analysis for the behavioral sciences. Hillsdale: Lawrence Erlbaum; 1988.
17. Federici E, Touche A, Choquart S, Avanti O, Fay L, Offord E, et al. High isoflavone content and estrogenic activity of 25 year-old Glycine max tissue cultures. Phytochemistry. 2003;64(3):717-24.
18. Imwalle DB, Gustafsson JA, Rissman EF. Lack of functional estrogen receptor beta influences anxiety behavior and serotonin content in female mice. Physiol Behav. 2005;84(1):157-63.
19. Rocha BA, Fleisher R, Schaeffer JM, Rohrer SP, Hickey GJ. 17 Beta-estradiol-induced antidepressant-like effect in the forced swim test is absent in estrogen receptor-beta knockout (BERKO) mice. Psychopharmacology. 2005;179(3):637-43.
20. Utian WH. Psychosocial and socioeconomic burden of vasomotor symptoms in menopause: a comprehensive review. Health Qual Life Outcomes. 2005;3(1):47.
21. Gingrich PM, Fogel CI. Herbal therapy use by perimenopausal women. J Obstet Gynecol Neonatal Nurs. 2003;32(2):181-9.
22. Fonseca AM, Bagnoli VR, Cardoso EB, Assis JS. Climatério: abordagem atual do diagnóstico e tratamento. RBM Rev Bras Med. 2004;61(1-2):65-9.
23. Davis SR. Phytoestrogen therapy for menopausal symptoms? BMJ. 2001;323(7309):354-5.
24. Abreu VG, Francischetti EA. Reposição hormonal: controvérsias. RBM Rev Bras Med. 2001;58(4):217-24.
25. Nagata C, Shimizu H, Takami R, Hayashi M, Takeda N, Yasuda K. Serum concentrations of estradiol and dehydroepiandrosterone sulfate and soy product intake in relation to psychologic well-being in periand postmenopausal Japanese women. Metabolism. 2000;49(12):1561-4.
26. Kok L, Kreijkamp-Kaspers S, Grobee DE, Lampe JW, van der Schouw YT. A randomized, placebo-controlled trial on the effects of soy protein containing isoflavones on quality of life in postmenopausal women. Menopause. 2005;12(1):56-62.
27. Morrison MF, Kallan MJ, Tem Have T, Katz I, Tweddy K, Battistini M. Lack of efficacy of estradiol for depression in postmenopausal women: a randomized, controlled trial. Biol Psychiatry. 2004;55(4):406-12.
28. Schmidt PJ, Nieman L, Danaceau MA, Tobin MB, Roca CA, Murphy JH, et al. Estrogen replacement in perimenopause-related depression: a preliminary report. Am J Obstet Gynecol. 2000;183(2):414-20.
29. Secreto G, Chiechi LM, Amadori A, Miceli R, Venturelli E, Valerio T, et al. Soy isoflavones and melatonin for the relief of climacteric symptoms: a multicenter, double-blind, randomized study. Maturitas. 2004;47(1):11-20.
30. Penotti M, Fabio E, Modena AB, Rinaldi M, Omodei U, Vigano P. Effect of soy-derived isoflavones on hot flushes, endometrial thickness, and the pulsatility index of the uterine and cerebral arteries. Fertil Steril. 2003;79(5):1112-7.
31. Demétrio FN, Reno Júnior J, Gonçalves MA, Gianfaldoni A, Halbe HW, Gorenstein C, et al. Terapia com estrógenos conjugados no humor de mulheres menopausadas: resultados preliminares. Rev Psiquiatr Clin (São Paulo). 2001;28(2):89-93.
32. Rowland IR, Wiseman H, Sanders TA, Adlercreutz H, Bowey EA. Interindividual variation in metabolism of soy isoflavones and lignans: influence of habitual diet on equol production by the gut microflora. Nutr Cancer. 2000;36(1):27-32.
33. Petri-Nahás EA, Nahás-Neto J, De Luca L, Traiman P, Pontes A, Dalben I. Benefits of soy germ isoflavones in postmenopausal women with contraindication for conventional hormone replacement therapy. Maturitas. 2004;48(4):372-80.
34. Han KK, Soares JM Jr, Haidar MA, de Lima GR, Baracat EC. Benefits of soy isoflavone therapeutic regimen on menopausal symptoms. Obstet Gynecol. 2002;99(3):389-94.
35. Huttner RP, Shepherd JE. Gonadal steroids, selective serotonin reuptake inhibitors, and mood disorders in women. Med Clin North Am. 2003;87(5):1065-76.
36. Sousa RL, Filizola RG, Moraes JLR. O efeito dominó dos fogachos: sintomatologia depressiva e insônia no climatério feminino. RBM Rev Bras Med. 2003;60(4):191-4.
37. Baird DD, Umbach DM, Lansdell L, Hughes CL, Setchell KD, Weiberg CR, et al. Dietary intervention study to assess estrogenicity of dietary soy among postmenopausal women. J Clin Endocrinol Metab. 1995;80(5):1685-90.
38. Davis SR, Briganti EM, Chen RQ, Dalais FS, Bailey M, Burger HG. The effects of Chinese medicinal herbs on postmenopausal vasomotor symptoms of Australian women: a randomized controlled trial. Med J Aust. 2001;174(2):68-71.
39. Rajewska J, Rybakowski JK. Depression in premenopausal women: gonadal hormones and serotonergic system assessed by D-fenfluramine challenge test. Prog Neuropsychopharmacol Biol Psychiatry. 2003;27(4):705-9.
40. Albert A, Altabre C, Baro F, Buendia E, Cabero A, Cancelo MJ, et al. Efficacy and safety of a phytoestrogen preparation derived from Glycine max (L.) Merr in climateric symptomatology: a multicentric, open, prospective and non-randomized trial. Phytomedicine. 2002;9(2):85-92.